7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid

Term ID

CHEBI:140272

Synonyms

(14E,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoic acid
7,16,17-trihydroxy-(8,10,12,14E,19Z)-docosapentaenoic acid
7,16,17-trihydroxy-omega3-docosapentaenoic acid
resolvin D2n-3 DPA
RvD2n-3 DPA

Definition

A docosanoid that is (14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid carrying three hydroxy substituents at positions 7, 16 and 17. An intermediate of specialised proresolving mediators

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: docosanoid hydroxy polyunsaturated fatty acid

docosanoid hydroxy polyunsaturated fatty acid Show first 5 Terms
has_role: human xenobiotic metabolite specialised pro-resolving mediator

human xenobiotic metabolite specialised pro-resolving mediator Show first 5 Terms
inverse is_conjugate_base_of: 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate

7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate Show first 5 Terms
is_conjugate_acid_of: 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate

7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate Show first 5 Terms

Phenotype

Phenotype resulting from 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid

Phenotype where environments contain 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid

Phenotype modified by environments containing 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid

Human Disease Model